4
Changes in Ownership
ANI PHARMACEUTICALS INC Filed Acc 0001104659-23-073894
HEAD OF R&D, COO-NOVITIUM OPS sold 40,000 shares at an average $51.75 ($2,070,012)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Shanmugam Muthusamy · HEAD OF R&D, COO-NOVITIUM OPS
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-06-20 | Sale : show line 1 in the form 10b5-1 | −14,657 | $51.93 | $761,138 | 32,750 | D |
| 2023-06-21 | Sale : show line 2 in the form 10b5-1 | −11,843 | $51.95 | $615,244 | 20,907 | D |
| 2023-06-22 | Sale : show line 3 in the form 10b5-1 | −13,500 | $51.38 | $693,630 | 7,407 | D |
| Open-market sales · 40,000 sh · avg $51.75 · $2,070,012 | ||||||
Loading xslF345X04/tm2319370-1_4seq1.xml…